Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Felipe Roitberg"'
Autor:
Khalid El Bairi, Dario Trapani, Sara Jamil Nidhamalddin, Shah Zeb Khan, Arman Reza Chowdhury, Csongor György Lengyel, Sadaqat Hussain, Baker Shalal Habeeb, Angelica Petrillo, Nabil Elhadi Omar, Sara Altuna, Fahmi Usman Seid, Essam Elfaham, Andreas Seeber, Felipe Roitberg, Alan Burguete-Torres, Safa El Kefi, Nazik Hammad, Miriam Mutebi, Ouissam Al Jarroudi, Nadia El Kadmiri, Giuseppe Curigliano, Said Afqir
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEOpen-access publishing expanded opportunities to give visibility to research results but was accompanied by the proliferation of predatory journals (PJos) that offer expedited publishing but potentially compromise the integrity of research and
Externí odkaz:
https://doaj.org/article/613946ab80c74ec390eb8a9c3f55f89c
Autor:
Dario Trapani, Kiu Tay-Teo, Megan E. Tesch, Felipe Roitberg, Manju Sengar, Sara C. Altuna, Michael J. Hassett, Armando A. Genazzani, Aaron S. Kesselheim, Giuseppe Curigliano
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5774-5791 (2022)
Background: Advances in cancer medicines have resulted in tangible health impacts, but the magnitude of benefits of approved cancer medicines could vary greatly. Health Technology Assessment (HTA) is a multidisciplinary process used to inform resourc
Externí odkaz:
https://doaj.org/article/f8f024b9d7d74d429ae34560c195d643
Autor:
Murallitharan Munisamy, Kingsley Ndoh, Ahmed Abdelbadee, Isthar Espejo, Florence Manjuh, Alexandra Tamas, Omolola Salako, Felipe Roitberg
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1194-1198 (2021)
Externí odkaz:
https://doaj.org/article/a1d71760e20a49f68b560e8b5f79bcf5
Autor:
Archita Srivastava, Matthew Jalink, Fabio Ynoe de Moraes, Christopher M. Booth, Scott R. Berry, Fidel Rubagumya, Felipe Roitberg, Manju Sengar, Nazik Hammad
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 925-933 (2021)
Existing literature has described the projected increase in cancer incidence and the associated deficiencies in the cancer workforce. However, there is currently a lack of research into the necessary policy and planning steps that can be taken to mit
Externí odkaz:
https://doaj.org/article/0fcc476a3f584602bacde1dce7d8c5e7
Autor:
Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Felipe Roitberg, Andre Ilbawi, Rachel Riera
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 342-352 (2021)
PURPOSEDelays and disruptions in health systems because of the COVID-19 pandemic were identified by a previous systematic review from our group. For improving the knowledge about the pandemic consequences for cancer care, this article aims to identif
Externí odkaz:
https://doaj.org/article/4a0bb822b42343c2bcaeee3c73f1e73a
Autor:
Rachel Riera, Ângela Maria Bagattini, Rafael Leite Pacheco, Daniela Vianna Pachito, Felipe Roitberg, Andre Ilbawi
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 311-323 (2021)
PURPOSEThere has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experie
Externí odkaz:
https://doaj.org/article/556e80b9162643248a5806beaa459f90
Publikováno v:
Preventive Medicine Reports, Vol 30, Iss , Pp 101987- (2022)
Oral cancer (OC) is a debilitating disease with a high mortality rate when diagnosed in advanced stage. Conversely, early-stage OC has a high survival rate, supporting a need for early detection programmes. A previous systematic review of clinical tr
Externí odkaz:
https://doaj.org/article/3254e6b349d0468698497ea27bd7096d
Autor:
Manju Sengar, Adam Fundytus, Wilma Hopman, C.S. Pramesh, Venkatraman Radhakrishnan, Prasanth Ganesan, Aju Mathew, Dorothy Lombe, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Roitberg, Elisabeth G.E. De Vries, Lorenzo Moja, André Ilbawi, Richard Sullivan, Christopher M. Booth
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEThe WHO essential medicines list (EML) guides selection of drugs for national formularies. Here, we evaluate which medicines are considered highest priority by Indian oncologists and the extent to which they are available in routine practice.M
Externí odkaz:
https://doaj.org/article/74b0e0207c1c4558b701adaaa1a9d423
Autor:
Avram E. Denburg, Adam Fundytus, Muhammad Saghir Khan, Scott C. Howard, Federico Antillon-Klussmann, Manju Sengar, Dorothy Lombe, Wilma Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Roitberg, Elisabeth G. E. De Vries, Lorenzo Moja, André Ilbawi, Richard Sullivan, Christopher M. Booth
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEAccess to essential cancer medicines is a major determinant of childhood cancer outcomes globally. The degree to which pediatric oncologists deem medicines listed on WHO's Model List of Essential Medicines for Children (EMLc) essential is unkn
Externí odkaz:
https://doaj.org/article/2d5ab5447b6e475f8db48039ee2567d8
Autor:
Pedro Aguiar Júnior, Carmelia Maria Noia Barreto, Felipe Roitberg, Gilberto Lopes Júnior, Auro del Giglio
Publikováno v:
São Paulo Medical Journal, Vol 137, Iss 6, Pp 505-511 (2020)
ABSTRACT BACKGROUND: Lung cancer is the fourth most common cancer in Brazil. In the 2000s, better understanding of molecular pathways led to development of epidermal growth factor receptor (EGFR)-targeted treatments that have improved outcomes. Howev
Externí odkaz:
https://doaj.org/article/eae3dcd5e72f465bb0d717efb9e78f1a